Australija - anglų - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - lamivudine, quantity: 300 mg; dolutegravir sodium, quantity: 52.6 mg (equivalent: dolutegravir, qty 50 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; povidone; mannitol; titanium dioxide; microcrystalline cellulose; sodium stearylfumarate; magnesium stearate; hypromellose; macrogol 400 - dovato (a fixed dose combination of dolutegravir and lamivudine) is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults and adolescents (from 12 years of age weighing at least 40kg): ? in antiretroviral treatment-na?ve patients with no antiretroviral treatment history who have no known or suspected resistance to either antiretroviral component; or ? to replace the current antiretroviral regimen in those who are virologically suppressed (hiv-1 rna less than 50 copies per ml) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to the integrase inhibitor class or lamivudine (see section 5.1 pharmacodynamic properties, clinical trials).

Australija - anglų - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - dolutegravir sodium, quantity: 10.5 mg (equivalent: dolutegravir, qty 10 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; mannitol; microcrystalline cellulose; povidone; polyvinyl alcohol; titanium dioxide; macrogol 3350; purified talc - tivicay and tivicay pd are indicated for the treatment of human immunodeficiency virus (hiv) infection in combination with other antiretroviral agents in adults and children of at least 4 weeks in age or older and weighing 3 kg or more (see section 4.4 special warnings and precautions for use, dual regimens).

Australija - anglų - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - dolutegravir sodium, quantity: 26.3 mg (equivalent: dolutegravir, qty 25 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; mannitol; microcrystalline cellulose; povidone; polyvinyl alcohol; titanium dioxide; macrogol 3350; purified talc; iron oxide yellow - tivicay and tivicay pd are indicated for the treatment of human immunodeficiency virus (hiv) infection in combination with other antiretroviral agents in adults and children of at least 4 weeks in age or older and weighing 3 kg or more (see section 4.4 special warnings and precautions for use, dual regimens).

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

laurus labs limited, india - dolutegravir sodium - tablet, film-coated - 50

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

hetero laboratories limited, india - dolutegravir tablets 50mg - oral tablet - 50

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

celltrion, inc., republic of korea - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - tablets - 50/300/300

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

macleods pharmaceuticals limited, india - dolutegravir sodium - film coated tablet - 10

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

hetero laboratories limited, india - dolutegravir tablets 50mg - oral tablet - 50

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

hetero laboratories limited, india - dolutegravir, lamivudine , tenofovir disoproxil fumarate tablets 50mg/300mg/300mg - oral tablet - 50/300/300

Tanzanija - anglų - Tanzania Medicinces & Medical Devices Authority

cipla quality chemical industries limited, uganda - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - tablets